ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in Tampa, FL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Non-Small-Cell Lung Carcinoma
Neoplasm Metastasis
Cancer
Ovarian Cancer
Colorectal Cancer
Endometrial Cancer

Breast Cancer trials near Tampa, FL, USA:

A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer

A Phase 1, open-label, dose-escalation clinical trial of MBQ-167 in participants with advanced Breast Cancer for whom Standard of C...

Enrolling
Breast Cancer Stage IV
Breast Cancer
Drug: MBQ-167

Phase 1

MBQ Pharma

Sarasota, Florida, United States and 3 other locations

The purpose of this study is to test the safety and tolerability of PMD-026 in patients with metastatic breast cancer. PMD-026 is a ...

Active, not recruiting
Metastatic Breast Cancer
Drug: fulvestrant
Drug: PMD-026

Phase 1, Phase 2

Phoenix Molecular Designs

Tampa, Florida, United States and 9 other locations

as a possible adjuvant treatment for Stage II or III Triple Negative Breast Cancer. This research study is studying the safety, tol...

Active, not recruiting
Breast Cancer
Biological: PVX-410
Biological: Durvalumab

Phase 1

Mass General Brigham
Mass General Brigham

Tampa, Florida, United States and 4 other locations

The purpose of this study is to find out the maximum tolerated dose (MTD) and/or recommended dose(s) for expansion (RDEs) of JNJ-101684362 (HLD-0117)...

Enrolling
Metastatic Breast Cancer
Drug: JNJ-101684362 (HLD-0117)

Phase 1

Janssen (J&J Innovative Medicine)
Janssen (J&J Innovative Medicine)

Sarasota, Florida, United States and 6 other locations

DESTINY-Breast07 will investigate the safety, tolerability, and anti-tumour activity of trastuzumab deruxtecan (T-DXd) in combination with o ...

Active, not recruiting
Metastatic Breast Cancer
Drug: Tucatinib
Drug: Durvalumab

Phase 1, Phase 2

AstraZeneca
AstraZeneca

St. Petersburg, Florida, United States and 71 other locations

A Phase 1 Dose Escalation and Expansion Study of AZD9833 Alone or in Combination in Women with ER Positive, HER2 Negative Advanced Breast Ca...

Active, not recruiting
ER+ HER2- Advanced Breast Cancer
Drug: AZD9833 with palbociclib
Drug: AZD9833 with capivasertib

Phase 1

AstraZeneca
AstraZeneca

Sarasota, Florida, United States and 16 other locations

to anti-HER2-based therapy plus endocrine therapy alone in improving the outcomes of subjects with hormone receptor-positive, HER2+ metastatic breast...

Active, not recruiting
Estrogen Receptor Positive Breast Cancer
HER-2 Positive Breast Cancer
Drug: palbociclib
Drug: trastuzumab

Phase 3

Alliance Foundation Trials

Clearwater, Florida, United States and 107 other locations

A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer....

Active, not recruiting
Advanced Breast Cancer
Drug: ARV-471
Drug: Fulvestrant

Phase 3

Pfizer
Pfizer

Tampa, Florida, United States and 319 other locations

OR in combination with Hormonal Therapy in subjects with HR+, HER2- locally advanced and unresectable (Stage III) or metastatic (Stage IV) breast...

Enrolling
Breast Cancer
Drug: RGT-419B
Drug: RGT-419B in combination with hormonal therapy

Phase 1

Regor Pharmaceuticals

Tampa, Florida, United States and 7 other locations

effective, when combined with chemotherapy, in treating people who has Human Epidermal Growth Factor Receptor 2 (HER2)-positive, early-stage breast...

Enrolling
Breast Cancer
HER2-positive Breast Cancer
Drug: Zanidatamab
Drug: Carboplatin

Phase 2

Jazz Pharmaceuticals
Jazz Pharmaceuticals

Lakeland, Florida, United States and 43 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems